Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2222-2232

  Day, Cheryl L ^a,b,c   Abrahams, Deborah A ^a   Lerumo, Lesedi ^a   Van Rensburg, Esme Janse ^a   Stone, Lynnett ^a   O'rie, Terrence ^a   Pienaar, Bernadette ^a   De Kock, Marwou ^a   Kaplan, Gilla ^d   Mahomed, Hassan ^a   Dheda, Keertan ^a   Hanekom, Willem A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPUTUM SMEAR; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; BACTERIAL LOAD; CELL PROLIFERATION; CELL SEPARATION; CYTOKINES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TUBERCULOSIS; YOUNG ADULT;

EID: 80052653924     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101122     Document Type: Article

References (57)

1. World Health Organization. 2010. Global Tuberculosis Control. World Health Organization, Geneva, Switzerland.
2. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162: 5407-5416. (Pubitemid 29307149)
3. Mogues, T., M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193: 271-280. (Pubitemid 32524511)
4. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186: 39-45. (Pubitemid 27304845)
5. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254. (Pubitemid 23344886)
6. Jouanguy, E., S. Lamhamedi-Cherradi, D. Lammas, S. E. Dorman, M. C. Fondanèche, S. Dupuis, R. Döffinger, F. Altare, J. Girdlestone, J. F. Emile, et al. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21: 370-378. (Pubitemid 29159572)
7. Pai, M., A. Zwerling, and D. Menzies. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149: 177-184.
8. Wallis, R. S., M. Pai, D. Menzies, T. M. Doherty, G. Walzl, M. D. Perkins, and A. Zumla. 2010. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375: 1920-1937.
9. Keane, J., S. Gershon, R. P. Wise, E. Mirabile-Levens, J. Kasznica, W. D. Schwieterman, J. N. Siegel, and M. M. Braun. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345: 1098-1104.
10. Bruns, H., C. Meinken, P. Schauenberg, G. Härter, P. Kern, R. L. Modlin, C. Antoni, and S. Stenger. 2009. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J. Clin. Invest. 119: 1167-1177.
11. Grotzke, J. E., A. C. Siler, D. A. Lewinsohn, and D. M. Lewinsohn. 2010. Secreted immunodominant Mycobacterium tuberculosis antigens are processed by the cytosolic pathway. J. Immunol. 185: 4336-4343.
12. Lewinsohn, D. M., J. E. Grotzke, A. S. Heinzel, L. Zhu, P. J. Ovendale, M. Johnson, and M. R. Alderson. 2006. Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway. J. Immunol. 177: 437-442. (Pubitemid 43939156)
13. Van der Wel, N., D. Hava, D. Houben, D. Fluitsma, M. Van Zon, J. Pierson, M. Brenner, and P. J. Peters. 2007. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129: 1287-1298. (Pubitemid 46962098)
14. Winau, F., S. Weber, S. Sad, J. De Diego, S. L. Hoops, B. Breiden, K. Sandhoff, V. Brinkmann, S. H. Kaufmann, and U. E. Schaible. 2006. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 24: 105-117. (Pubitemid 43077204)
15. Lazarevic, V., D. Nolt, and J. L. Flynn. 2005. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J. Immunol. 175: 1107-1117. (Pubitemid 41094997)
16. Smith, S. M., M. R. Klein, A. S. Malin, J. Sillah, K. Huygen, P. Andersen, K. P. McAdam, and H. M. Dockrell. 2000. Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect. Immun. 68: 7144-7148. (Pubitemid 32463432)
17. Andersson, J., A. Samarina, J. Fink, S. Rahman, and S. Grundström. 2007. Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis. Infect. Immun. 75: 5210-5222. (Pubitemid 350033607)
18. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687. (Pubitemid 43237609)
19. Blackburn, S. D., H. Shin, W. N. Haining, T. Zou, C. J. Workman, A. Polley, M. R. Betts, G. J. Freeman, D. A. Vignali, and E. J. Wherry. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29-37.
20. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354. (Pubitemid 44435155)
21. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
22. Kaufmann, D. E., D. G. Kavanagh, F. Pereyra, J. J. Zaunders, E. W. Mackey, T. Miura, S. Palmer, M. Brockman, A. Rathod, A. Piechocka-Trocha, et al. 2007. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8: 1246-1254. (Pubitemid 350011764)
23. Urbani, S., B. Amadei, D. Tola, M. Massari, S. Schivazappa, G. Missale, and C. Ferrari. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 80: 11398-11403. (Pubitemid 44706581)
24. Kannanganat, S., C. Ibegbu, L. Chennareddi, H. L. Robinson, and R. R. Amara. 2007. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J. Virol. 81: 8468-8476. (Pubitemid 47242819)
25. Makedonas, G., and M. R. Betts. 2011. Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV. Immunol. Rev. 239: 109-124.
26. Kannanganat, S., B. G. Kapogiannis, C. Ibegbu, L. Chennareddi, P. Goepfert, H. L. Robinson, J. Lennox, and R. R. Amara. 2007. Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines. J. Virol. 81: 12071-12076. (Pubitemid 47623838)
27. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789. (Pubitemid 43882629)
28. Ciuffreda, D., D. Comte, M. Cavassini, E. Giostra, L. Bühler, M. Perruchoud, M. H. Heim, M. Battegay, D. Genné, B. Mulhaupt, et al. 2008. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur. J. Immunol. 38: 2665-2677.
29. Darrah, P. A., S. T. Hegde, D. T. Patel, R. W. Lindsay, L. Chen, M. Roederer, and R. A. Seder. 2010. IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform. J. Exp. Med. 207: 1421-1433.
30. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850. (Pubitemid 47038186)
31. Forbes, E. K., C. Sander, E. O. Ronan, H. McShane, A. V. Hill, P. C. Beverley, and E. Z. Tchilian. 2008. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol. 181: 4955-4964.
32. Sutherland, J. S., I. M. Adetifa, P. C. Hill, R. A. Adegbola, and M. O. Ota. 2009. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 39: 723-729.
33. Caccamo, N., G. Guggino, S. A. Joosten, G. Gelsomino, P. Di Carlo, L. Titone, D. Galati, M. Bocchino, A. Matarese, A. Salerno, et al. 2010. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol. 40: 2211-2220.
34. Streitz, M., S. Fuhrmann, F. Powell, A. Quassem, L. Nomura, H. Maecker, P. Martus, H. D. Volk, and F. Kern. 2011. Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination. J. Infect. Dis. 203: 378-382.
35. Harari, A., V. Rozot, F. B. Enders, M. Perreau, J. M. Stalder, L. P. Nicod, M. Cavassini, T. Calandra, C. L. Blanchet, K. Jaton, et al. 2011. Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat. Med. 17: 372-376.
36. Hesseling, A. C., G. Walzl, D. A. Enarson, N. M. Carroll, K. Duncan, P. T. Lukey, C. Lombard, P. R. Donald, K. A. Lawrence, R. P. Gie, et al. 2010. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int. J. Tuberc. Lung Dis. 14: 560-570.
37. Gopi, P. G., V. Chandrasekaran, R. Subramani, T. Santha, A. Thomas, N. Selvakumar, and P. R. Narayanan. 2006. Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Indian J. Med. Res. 123: 807-814. (Pubitemid 44269948)
38. Ralph, A. P., M. Ardian, A. Wiguna, G. P. Maguire, N. G. Becker, G. Drogumuller, M. J. Wilks, G. Waramori, E. Tjitra, E. Sandjaja, et al. 2010. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65: 863-869.
39. De Kantor, I. N., S. J. Kim, T. Frieden, A. Laszlo, F. Luelmo, P.-Y. Norval, H. Rieder, P. Valenzuela, and K. Weyer. 1998. Laboratory Services in Tuberculosis Control. World Health Organization, Geneva.
40. Toman, K. 1979. Tuberculosis Case Finding and Chemotherapy: Questions and Answers. World Health Organization, Geneva.
41. Hanekom, W. A., J. Hughes, M. Mavinkurve, M. Mendillo, M. Watkins, H. Gamieldien, S. J. Gelderbloem, M. Sidibana, N. Mansoor, V. Davids, et al. 2004. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J. Immunol. Methods 291: 185-195. (Pubitemid 39164348)
42. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
43. Day, C. L., N. Mkhwanazi, S. Reddy, Z. Mncube, M. Van der Stok, P. Klenerman, and B. D. Walker. 2008. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J. Infect. Dis. 197: 990-999. (Pubitemid 351590027)
44. Grotzke, J. E., M. J. Harriff, A. C. Siler, D. Nolt, J. Delepine, D. A. Lewinsohn, and D. M. Lewinsohn. 2009. The Mycobacterium tuberculosis phagosome is a HLA-I processing competent organelle. PLoS Pathog. 5: e1000374.
45. Grotzke, J. E., and D. M. Lewinsohn. 2005. Role of CD8+ T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes Infect. 7: 776-788. (Pubitemid 40720433)
46. Pai, M., K. Dheda, J. Cunningham, F. Scano, and R. O'Brien. 2007. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect. Dis. 7: 428-438. (Pubitemid 46779096)
47. Millington, K. A., J. A. Innes, S. Hackforth, T. S. Hinks, J. J. Deeks, D. P. Dosanjh, V. Guyot-Revol, R. Gunatheesan, P. Klenerman, and A. Lalvani. 2007. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J. Immunol. 178: 5217-5226. (Pubitemid 46595306)
48. Einarsdottir, T., E. Lockhart, and J. L. Flynn. 2009. Cytotoxicity and secretion of gamma interferon are carried out by distinct CD8 T cells during Mycobacterium tuberculosis infection. Infect. Immun. 77: 4621-4630.
49. Yi, J. S., M. A. Cox, and A. J. Zajac. 2010. T-cell exhaustion: characteristics, causes and conversion. Immunology 129: 474-481.
50. Deeks, S. G., and B. D. Walker. 2007. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27: 406-416. (Pubitemid 47418678)
51. Harari, A., V. Dutoit, C. Cellerai, P. A. Bart, R. A. Du Pasquier, and G. Pantaleo. 2006. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol. Rev. 211: 236-254. (Pubitemid 43882976)
52. Pantaleo, G., and A. Harari. 2006. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6: 417-423.
53. Williams, M. A., A. J. Tyznik, and M. J. Bevan. 2006. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441: 890-893.
54. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
55. Barry, C. E., III, H. I. Boshoff, V. Dartois, T. Dick, S. Ehrt, J. Flynn, D. Schnappinger, R. J. Wilkinson, and D. Young. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7: 845-855.
56. Lin, P. L., and J. L. Flynn. 2010. Understanding latent tuberculosis: a moving target. J. Immunol. 185: 15-22.
57. Berry, M. P. R., C. M. Graham, F. W. McNab, Z. Xu, S. A. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.